<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS137319</article-id>
<article-id pub-id-type="doi">10.1101/2021.10.20.464686</article-id>
<article-id pub-id-type="archive">PPR409983</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>S100A8 and S100A9, biomarkers of SARS-Cov2-infected patients, suppress HIV replication in primary macrophages</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Oguariri</surname>
<given-names>Raphael M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="fn" rid="FN1">†</xref>
<xref ref-type="fn" rid="FN3">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brann</surname>
<given-names>Terrence W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="fn" rid="FN2">#</xref>
<xref ref-type="fn" rid="FN3">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adelsberger</surname>
<given-names>Joseph W.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Qian</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goswami</surname>
<given-names>Suranjana</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mele</surname>
<given-names>Anthony R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Imamichi</surname>
<given-names>Tomozumi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">**</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick MD, 21702, USA</aff>
<aff id="A2">
<label>2</label>AIDS monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick MD, 21702, USA</aff>
<author-notes>
<corresp id="CR1">
<label>**</label>Corresponding author: Building 550, Room 126, P.O. Box B, Frederick National Laboratory, Frederick, 21702, MD, USA. Tel: +1-301-846-5450, Fax +1-301-846-6762. <email>timamichi@mail.nih.gov</email>
</corresp>
<fn id="FN1" fn-type="current-aff">
<label>†</label>
<p id="P1">Current affiliation: University of Maryland Global Campus, 1616 McCormick Drive. Largo, MD 20774, USA</p>
</fn>
<fn id="FN2" fn-type="current-aff">
<label>#</label>
<p id="P2">Current affiliation: Denovo Biotechnology, Ijamsville, MD 21754, USA.</p>
</fn>
<fn fn-type="equal" id="FN3">
<label>*</label>
<p id="P3">Both authors equally contributed in this project.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="preprint">
<day>21</day>
<month>10</month>
<year>2021</year>
</pub-date>
<permissions>
<ali:free_to_read/>
<license>
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P4">S100A8 and S100A9 are members of the Alarmin family; these proteins are abundantly expressed in neutrophils and form a heterodimer complex. Recently, both proteins were identified as novel biomarkers of SARS-CoV-2 infection and were shown to play key roles in inducing an aggressive inflammatory response by mediating the release of large amounts of pro-inflammatory cytokines, called the “cytokine storm.” Although co-infection with SARS-CoV-2 in people living with HIV-1 may result in an immunocompromised status, the role of the S100A8/A9 complex in HIV-1 replication in primary T cells and macrophages is still unclear. Here, we evaluated the roles of the proteins in HIV replication to elucidate their functions. We found that the complex had no impact on virus replication in both cell types; however, the subunits of S100A8 and S100A9 inhibits HIV in macrophages. These findings provide important insights into the regulation of HIV viral loads in SARS-CoV2 co-infection.</p>
</abstract>
<kwd-group>
<kwd>S100A8</kwd>
<kwd>S100A9</kwd>
<kwd>CD4(+) T cells</kwd>
<kwd>monocyte-derived macrophages</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P5">S100A8 and S100A9 also known as myeloid-related protein (MRP) 8 and MRP14 are members of the S100 calcium binding protein family and belong to alarmin family protein [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref>]. They are low-molecular-weight (9–14 kDa) acidic proteins with important regulatory functions, including regulation of calcium buffering, cell differentiation, proliferation, cytoskeletal–membrane interactions, embryogenesis, cell migration, and inflammation [<xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R5">5</xref>]. The expression of human S100A8 and S100A9 are associated with acute and chronic inflammatory diseases [<xref ref-type="bibr" rid="R5">5</xref>–<xref ref-type="bibr" rid="R7">7</xref>]. S100A8 and S100A9 are expressed as homodimers or heterodimer complexes (S100A8/A9) and are constitutively expressed in neutrophils and monocytes [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8">8</xref>]. They are not detected in resting tissue macrophages and lymphocytes but induced in macrophages upon stimulation [<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R9">9</xref>]. S100A8, S100A9 and S100A8/A9 are chemoattractants for neutrophils [<xref ref-type="bibr" rid="R10">10</xref>] and stimulate the neutrophils’ adhesion to fibronectin [<xref ref-type="bibr" rid="R11">11</xref>]. It is also reported that S100A9 and S100A8/A9 enhance monocyte transmigration across endothelial cells [<xref ref-type="bibr" rid="R12">12</xref>].</p>
<p id="P6">During inflammation, the concentration of S100A8 and S100A9 in serum may rise up to near 100 μg /mL at local sites of inflammation [<xref ref-type="bibr" rid="R13">13</xref>]. Moreover, elevated serum levels of S100A8/A9 have recently been reported in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Additionally, the S100A8/A9 complex released from neutrophils is considered a biomarker of Covid-19 infection [<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>] and is involved in the induction of cytokine storms [<xref ref-type="bibr" rid="R16">16</xref>]. It is reported that S100A8 and S100A9 complex is an endogenous ligand of Toll-like receptor 4 (TLR4) on dendritic cells (DC) and a recent study using primary dendritic cells demonstrated that cytosolic S100A9 suppresses HIV replication by inhibiting reverse transcription [<xref ref-type="bibr" rid="R17">17</xref>]. On contrary, S100A8 or S100A9 have been reported as HIV inducers/activators in studies using T cell lines or promonocytic cell line [<xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref>], however, a role of each S100A protein on HIV replication in primary cells were not investigated well yet.</p>
<p id="P7">Co-infection with SARS-CoV2 in people living with HIV (PLWH) with poorly controlled viral load may result in an immunocompromised status. Although the increase of S100A8/A9 in plasma is reported, the impact of extracellular S100A8/A9 on HIV replication in primary cells has not been thoroughly investigated. Therefore, in this study, we assessed the roles of S100A8 and S100A9 in HIV replication in primary macrophages and T cells.</p>
</sec>
<sec id="S2" sec-type="materials | methods">
<title>Materials and Methods</title>
<sec id="S3">
<title>Cells and Reagents</title>
<p id="P8">Peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood of healthy donors as previously described [<xref ref-type="bibr" rid="R20">20</xref>], after we obtained approval from the National Institute of Allergy and Infectious Diseases Institutional Review Board. CD4<sup>+</sup> T cells and CD14<sup>+</sup> monocytes were isolated from PBMCs using CD4 and CD14 beads (Miltenyi Biotech, Auburn, CA, USA), respectively. PBMCs and CD4<sup>+</sup> T cells were stimulated with 5 μg/ml of PHA (Sigma Aldrich, St Louis, MO, USA), and CD14<sup>+</sup> monocytes were differentiated into macrophages (MDMs) using Macrophage-colony stimulatory factor (M-CSF) (R&amp;D systems, Minneapolis, MN, USA) as previously described [<xref ref-type="bibr" rid="R20">20</xref>]. Recombinant human S100A8 and S100A9 were obtained from Sino Biological Inc. (Beijing, China) and S100A8/S100A9 complex was purchased from R&amp;D systems. Anti-SPTBN and anti-b-actin antibodies were obtained from Abcam (Waltham, MA, USA) and Sigma Aldrich, respectively.</p>
</sec>
<sec id="S4">
<title>HIV replication assay</title>
<p id="P9">The HIV stocks of X4 (HIV<sub>NL4.3</sub>) [<xref ref-type="bibr" rid="R21">21</xref>] and R5 (HIV<sub>AD8</sub>) [<xref ref-type="bibr" rid="R22">22</xref>] viruses were prepared by transfection of the plasmid encoding each HIV strain into HEK293T cells, and the viruses were then purified from culture supernatants of the transfected cells using ultracentrifugation with 20% sucrose at 100,000 × <italic>g</italic> for 2h and infectious titers were determined by the endpoint assay as previously described [<xref ref-type="bibr" rid="R23">23</xref>].The HIV replication assay was performed as previously described [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R24">24</xref>]. Briefly, PHA-stimulated CD4<sup>+</sup> T cells were infected with X4 HIV-1 (MOI=0.001), and MDMs were infected with R5 HIV-1 (MOI=0.05). The infected PBMCs and CD4+ T cells were cultured at 37°C in humidified air with 5% CO<sub>2</sub> in the presence of 20 U/mL of IL-2 (Roche Diagnosis, Indianapolis, IN, USA), with various concentrations of S100A8 or S100A9 in RPMI-140 (Thermo Fisher, Waltham, MA) containing 10% fetal bovine serum (FBS; Cytiva, Marlborough, MA) [<xref ref-type="bibr" rid="R23">23</xref>]. HIV-infected MDMs were cultured for 14 days in Dulbecco’s modified Eagle medium (Thermo Fisher) containing 10% FBS. Culture medium was changed every three to 4 days with 50% concentration of S100 protein. The level of HIV-1 replication was determined by measuring p24 antigen in the culture supernatant using a kit (Perkin Elmer Inc, Shelton, CT, USA).</p>
</sec>
<sec id="S5">
<title>Quantitation of HIV-1 Proviral DNA Copy Number</title>
<p id="P10">MDMs were treated or untreated with 1 μg/mL of S100A8 or S100A9 and cultured for 24 h at 37 °C. Pretreated cells were infected with DNase I-treated HIV<sub>Ad8</sub> virus for 2 h at 37 °C. Cells were washed and cultured for additional 24 h. Absolute numbers of copies of proviral DNA were determined by real time PCR using custom made probes (Thermo Fisher). To obtain absolute proviral DNA copy numbers, standard curves were generated using serial dilutions of a plasmid encoding HIV gag region (pHIVgag) and RNaseP gene (pRNaseP) as previously described [<xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref>].</p>
</sec>
<sec id="S6">
<title>FACS analysis</title>
<p id="P11">MDMs were cultured at 37 °C in humidified air with 5% CO<sub>2</sub> for 24 h in the presence of media alone, 1 μg/ml of S100A8 or S100A9. After pretreatment, cells were washed with cold PBS, and then stained with fluorescein isothiocyanate (FITC)-conjugated anti-CD4 (BD-PharMingen, San Diego, CA, USA), or PE conjugated anti-CCR5 or anti-CD4 as previously described [<xref ref-type="bibr" rid="R26">26</xref>]. The stained cells were analyzed by using a Coulter XL flow cytometer (Beckman-Coulter, Fullerton, CA, USA). Events were collected by gating on forward and 90° light scatter. Positive fluorescence was determined using a matched isotype control IgG conjugated with FITC or PE (BD-PharMingen).</p>
</sec>
<sec id="S7">
<title>HIV binding Assay</title>
<p id="P12">MDMs cells were pretreated with or without 1 μg/ml of S100A8 or S100A9 for 24 h. Cells were then incubated with DNase-treated HIV-1 at 4 °C for 2 h, followed by washing with ice-cold PBS. Total RNA was isolated using RNeasy Kit (Qiagen, Germantown, MD, USA) and reverse transcribed as previously described [<xref ref-type="bibr" rid="R24">24</xref>]. HIV-1 binding amount was evaluated by measuring HIV gag gene expression by real time PCR as described previously [<xref ref-type="bibr" rid="R24">24</xref>].</p>
</sec>
<sec id="S8">
<title>Western blotting</title>
<p id="P13">Western blotting was performed as previously described [<xref ref-type="bibr" rid="R27">27</xref>]. MDMs were treated with or without 1 μg/ml of S100A8, S100A9 or 10 ng/mL of LPS for 2 days. Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer(Boston, MA USA) supplemented with protease inhibitors (Sigma-Aldrich) and phosphatase inhibitor (Thermo Scientific, Rockford, IL). Protein amounts were determined using the BCA protein assay kit (Thermo Scientific). A total of 20 μg of whole cell lysate were resolved on a 3-8% Tris-Acetate NuPAGE (Invitrogen) and analyzed by immunoblotting with anti-SPTBN1, anti- APOBEC3G, (Abcam, Cambridge, MA, USA), or anti-Beta-Actin (Santa Cruz) as previously described [<xref ref-type="bibr" rid="R27">27</xref>]. Signals on the membranes were detected using HRP-conjugated anti-rabbit or anti-mouse immunoglobulins (GE Healthcare) with an ECL-plus kit (GE Healthcare). The intensity of the bands was analyzed by NIH Image J (<ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/ij/">http://rsbweb.nih.gov/ij/</ext-link>).</p>
</sec>
<sec id="S9">
<title>Statistical analysis</title>
<p id="P14">Statistical analysis was performed using the Analysis ToolPak from Microsoft Excel. Results were representative of at least three independent experiments. The values were expressed as mean and SD of individual samples. Statistical significance was determined by the Student’s t test. A p-value &lt; 0.05 was considered a significant difference between the experimental groups.</p>
</sec>
</sec>
<sec id="S10" sec-type="results | discussion">
<title>Results and Discussion</title>
<p id="P15">To assess the function of each protein in HIV replication in primary cells, the activated CD4<sup>+</sup>-T cells and MDMs were infected with X4 HIV-1 and R5 HIV-1, respectively [<xref ref-type="bibr" rid="R23">23</xref>]. The infected cells were cultured at 37°C under physiological concentrations (0–10 μg/mL) of recombinant S100A8/A9 by exchanging half of the medium every 3–4 days with fresh medium containing the same concentration of protein[<xref ref-type="bibr" rid="R23">23</xref>]. As shown in <xref ref-type="fig" rid="F1">Fig. 1a and 1b</xref>, the S100A8/A9 complex had no impact on HIV replication in CD4<sup>+</sup> T cells and MDMs. S100A8 and S100A9 have been reported to induce HIV in T cell lines [<xref ref-type="bibr" rid="R19">19</xref>]; thus, we assessed the impact of each recombinant protein on HIV replication in primary T cells and MDMs. HIV-infected T cells and MDMs were cultured in the presence of different concentration of S100A8 or S100A9. Interestingly, although both proteins had no effect on HIV replication in primary T cells (<xref ref-type="fig" rid="F1">Fig. 1c</xref>), they inhibited HIV replication in MDMs in a dose-dependent manner (<xref ref-type="fig" rid="F1">Fig. 1d</xref>). In the presence of 10 μg/mL S100A8 and S100A9, HIV replication in MDMs was suppressed by 89±10% and 79±5.4% (n=3, p&lt;0.05), respectively, indicating that S100A8 and S100A9 exhibited anti-HIV effects in primary MDMs.</p>
<p id="P16">To further characterize these anti-HIV effect, we pulse-treated MDMs with 1 μg/mL of each protein for 24 h and then infected the pre-treated cells with HIV. Infected cells were cultured in the absence of S100 proteins and viral replication was monitored. Monitoring of viral replication (<xref ref-type="fig" rid="F1">Fig. 1e</xref>) showed that the S100A8- and S100A9-treatment were sufficient to suppress HIV replication by 65±9.9% and 77±6.7% (p&lt;0.05, n=3), respectively. This inhibitory effect may involve suppression of HIV infection or interference with the viral cycle after infection. To further elucidate the inhibitory mechanism, we first compared the expression levels of CD4 and CCR5 in pulse-treated cells using FACS, as previously described. FACS analysis demonstrated no changes in CD4 (<xref ref-type="fig" rid="F1">Fig. 1f</xref>) or CCR5 expression (<xref ref-type="fig" rid="F1">Fig. 1g</xref>). Thus, we assumed that the inhibition was caused by suppression of virus binding to receptors. Consequently, we conducted HIV binding assays using qRT-PCR. Pretreated cells were incubated with HIV for 2h at 4°C. Total RNA (cellular RNA and viral RNA on the cell surface) was extracted, and qRT-PCR was then conducted. HIV gag viral RNA levels were normalized to <italic>GAPDH</italic> mRNA levels, and the amount of HIV RNA was then compared. Pre-treatment had no effect on HIV binding (<xref ref-type="fig" rid="F1">Fig. 1h</xref>). Next, we assessed the inhibitory effects of reverse transcription by measuring the copy numbers of proviral DNA using qPCR. HIV-infected cells were cultured for 24 h, and genomic DNA was extracted and subjected to qPCR as previously described [<xref ref-type="bibr" rid="R23">23</xref>]. S100A8 and S100A9-treatment decreased proviral DNA copy numbers by 63± 3.1% and 63±9.2 % (p&lt;0.01, n=3) (<xref ref-type="fig" rid="F1">Fig. 1i</xref>), suggesting that pre-treatment suppressed HIV replication during reverse transcription after infection. We previously reported that Spectrin β Non-Erythrocytic 1 (SPTBN1) plays a key role on HIV replication in MDMs and downregulation of the expression of SPTBN1 suppressed HIV reverse transcription [<xref ref-type="bibr" rid="R23">23</xref>]. To address a potential mechanism of S100A8 or S100A9-mediated RT suppression, we conducted Western blotting using cell lysates from the pre-treated cells and anti-SPTBN1 antibody [<xref ref-type="bibr" rid="R23">23</xref>]. S100A8- and S100A9-treatment demonstrated a partial downregulation of SPTBN1 expression to 58±24% and 60±28% (p&gt;0.05, n=3), respectively (<xref ref-type="fig" rid="F1">Fig. 1j</xref>), indicating that SPTBN1 may be involved in HIV inhibition in the pretreated cells. HIV reverse transcription is regulated by many host-required factors [<xref ref-type="bibr" rid="R23">23</xref>]; thus, further studies are needed to elucidate the mechanisms mediating these inhibitory effects.</p>
<p id="P17">The concentrations of S100A8/A9 proteins are increased in patients with SARS-CoV2 infection [<xref ref-type="bibr" rid="R14">14</xref>], and these proteins are involved in the cytokine storm. Thus, we speculated that elevation of the concentrations of both proteins may affect HIV replication in patients with HIV infection in whom the disease is poorly controlled by combination antiretroviral therapy because HIV replication was shown to be enhanced by S100A8 and S100A9 in a previous report [<xref ref-type="bibr" rid="R19">19</xref>]. However, our data indicated that the complex proteins did not alter HIV replication in primary cells, suggesting that although the protein concentration was increased in PLWH co-infected with SARS-CoV2, these proteins may not directly enhance HIV replication and instead each subunit may inhibit HIV replication. S100A9 is an intracellular HIV inhibitor that suppresses the HIV reverse transcription reaction[<xref ref-type="bibr" rid="R17">17</xref>], and our data demonstrated that the protein is an extracellular inhibitor; therefore, S100A9 may have applications as therapeutic reagents. Impact of S100A8 and S100A9 in co-infection with SARS-CoV2 and other viruses, such as influenza virus or Hepatitis C virus, should also be considered, and further studies may provide important insights into the regulation of viral load in SARS-CoV2 co-infection.</p>
</sec>
</body>
<back>
<ack id="S11">
<title>Acknowledgments</title>
<p>All authors thank Dr. HC. Lane for supporting this project and Drs. W. Cheng, H. Sui and S. Laverdure for critical reading. The plasmid encoding HIV<sub>NL4.3</sub> and HIV<sub>AD8</sub> gene were obtained from Dr. M. Martin (NIAID, Bethesda, MD, USA).</p>
<sec id="S12">
<title>Funding Status</title>
<p>This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported [in part] by the National Institute of Allergy and Infectious Disease. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.</p>
</sec>
</ack>
<fn-group>
<fn id="FN4" fn-type="con">
<p id="P18">
<bold>Authorship confirmation:</bold>
</p>
<p id="P19">All authors read the final version of the manuscript and agreed to the context in the manuscript.</p>
</fn>
<fn id="FN5" fn-type="conflict">
<p id="P20">
<bold>Conflicts of Interest</bold>:</p>
<p id="P21">All authors declare that there are no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>[1]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foell</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Proinflammatory S100 proteins in arthritis and autoimmune disease</article-title>
<source>Arthritis Rheum</source>
<year>2004</year>
<volume>50</volume>
<fpage>3762</fpage>
<lpage>3771</lpage>
<pub-id pub-id-type="doi">10.1002/art.20631</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>[2]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vogl</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sorg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sunderkotter</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules</article-title>
<source>Trends Immunol</source>
<year>2003</year>
<volume>24</volume>
<fpage>155</fpage>
<lpage>158</lpage>
</element-citation>
</ref>
<ref id="R3">
<label>[3]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donato</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>S100: a multigenic family of calcium-modulated proteins of theEF-hand type with intracellular and extracellular functional roles</article-title>
<source>Int J Biochem Cell Biol</source>
<year>2001</year>
<volume>33</volume>
<fpage>637</fpage>
<lpage>668</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>[4]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimbaldeston</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Geczy</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Tedla</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Finlay-Jones</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>S100A8 induction in keratinocytes by ultraviolet A irradiation is dependent on reactive oxygen intermediates</article-title>
<source>J Invest Dermatol</source>
<year>2003</year>
<volume>121</volume>
<fpage>1168</fpage>
<lpage>1174</lpage>
<pub-id pub-id-type="doi">10.1046/j.1523-1747.2003.12561.x</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>[5]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerkhoff</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Klempt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sorg</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)</article-title>
<source>Biochim Biophys Acta</source>
<year>1998</year>
<volume>1448</volume>
<fpage>200</fpage>
<lpage>211</lpage>
</element-citation>
</ref>
<ref id="R6">
<label>[6]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imamichi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wahl</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>McCartney-Francis</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Expression and cloning of migration inhibitory factor-related protein (MRP)8 and MRP14 in arthritis-susceptible rats</article-title>
<source>Biochem Biophys Res Commun</source>
<year>1993</year>
<volume>194</volume>
<fpage>819</fpage>
<lpage>825</lpage>
</element-citation>
</ref>
<ref id="R7">
<label>[7]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odink</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cerletti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bruggen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clerc</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Tarcsay</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zwadlo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gerhards</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schlegel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sorg</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis</article-title>
<source>Nature</source>
<year>1987</year>
<volume>330</volume>
<fpage>80</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1038/330080a0</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>[8]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burwinkel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>van den Bos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Goebeler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vollmer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sorg</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation,are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner</article-title>
<source>Blood</source>
<year>1993</year>
<volume>82</volume>
<fpage>1875</fpage>
<lpage>1883</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>[9]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goebeler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van den Bos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sorg</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Expression of calcium-binding proteins MRP8 and MRP14 is associated with distinct monocytic differentiation pathways in HL-60 cells</article-title>
<source>Biochem Biophys Res Commun</source>
<year>1993</year>
<volume>191</volume>
<fpage>565</fpage>
<lpage>570</lpage>
</element-citation>
</ref>
<ref id="R10">
<label>[10]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newton</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Hogg</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils</article-title>
<source>J Immunol</source>
<year>1998</year>
<volume>160</volume>
<fpage>1427</fpage>
<lpage>1435</lpage>
</element-citation>
</ref>
<ref id="R11">
<label>[11]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryckman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vandal</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tessier</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion</article-title>
<source>J Immunol</source>
<year>2003</year>
<volume>170</volume>
<fpage>3233</fpage>
<lpage>3242</lpage>
</element-citation>
</ref>
<ref id="R12">
<label>[12]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eue</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pietz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Storck</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Klempt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sorg</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Transendothelial migration of 27E10+ human monocytes</article-title>
<source>Int Immunol</source>
<year>2000</year>
<volume>12</volume>
<fpage>1593</fpage>
<lpage>1604</lpage>
</element-citation>
</ref>
<ref id="R13">
<label>[13]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frosch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Strey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vogl</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wulffraat</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Kuis</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sunderkotter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Harms</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sorg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis</article-title>
<source>Arthritis Rheum</source>
<year>2000</year>
<volume>43</volume>
<fpage>628</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="doi">10.1002/1529-0131(200003)43:3&lt;628::aid-anr20&gt;3.0.co;2-x</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>[14]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meroni</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Infantino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buhler</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Fritzler</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Circulating Calprotectin as a Biomarker of COVID-19 Severity</article-title>
<source>Expert Rev Clin Immunol</source>
<year>2021</year>
<volume>17</volume>
<fpage>431</fpage>
<lpage>443</lpage>
<pub-id pub-id-type="doi">10.1080/1744666x.2021.1905526</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>[15]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silvin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chapuis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dunsmore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Goubet</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Dubuisson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Derosa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Almire</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hénon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kosmider</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Droin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rameau</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<fpage>1401</fpage>
<lpage>1418</lpage>
<elocation-id>e1418</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.08.002</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>[16]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19</article-title>
<source>Cell Host &amp; Microbe</source>
<year>2021</year>
<volume>29</volume>
<fpage>222</fpage>
<lpage>235</lpage>
<elocation-id>e224</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.chom.2020.12.016</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>[17]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maarifi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lagisquet</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hertel</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Bonaventure</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chamontin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Moncorgé</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Tauziet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mombled</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Papin</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells</article-title>
<source>Embo j</source>
<year>2021</year>
<volume>40</volume>
<elocation-id>e106540</elocation-id>
<pub-id pub-id-type="doi">10.15252/embj.2020106540</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>[18]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashemi</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Mollenhauer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Madsen</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Sha</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Nacken</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Moyer</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Sorg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Spear</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication</article-title>
<source>Aids</source>
<year>2001</year>
<volume>15</volume>
<fpage>441</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1097/00002030-200103090-00002</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>[19]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryckman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Robichaud</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cantin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Tessier</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes</article-title>
<source>J Immunol</source>
<year>2002</year>
<volume>169</volume>
<fpage>3307</fpage>
<lpage>3313</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.169.6.3307</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>[20]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fakruddin</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Gorelick</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Adelsberger</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Garcia-Pineres</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Imamichi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27</article-title>
<source>Blood</source>
<year>2007</year>
<volume>109</volume>
<fpage>1841</fpage>
<lpage>1849</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2006-02-001578</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>[21]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adachi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gendelman</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Koenig</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Folks</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Willey</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rabson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone</article-title>
<source>J Virol</source>
<year>1986</year>
<volume>59</volume>
<fpage>284</fpage>
<lpage>291</lpage>
</element-citation>
</ref>
<ref id="R22">
<label>[22]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theodore</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Englund</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Buckler-White</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buckler</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Peden</surname>
<given-names>KW</given-names>
</name>
</person-group>
<article-title>Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions</article-title>
<source>AIDS Res Hum Retroviruses</source>
<year>1996</year>
<volume>12</volume>
<fpage>191</fpage>
<lpage>194</lpage>
</element-citation>
</ref>
<ref id="R23">
<label>[23]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lidie</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Adelsberger</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dewar</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation</article-title>
<source>J Exp Med</source>
<year>2013</year>
<volume>210</volume>
<fpage>517</fpage>
<lpage>534</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20120572</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>[24]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oguariri</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Adelsberger</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Rupert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baseler</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>HC</given-names>
</name>
<etal/>
</person-group>
<article-title>lnterleukin-2 inhibits HIV-1 replication in some human T cell lymphotrophic virus-1-infected cell lines via the induction and incorporation of APOBEC3G into the virion</article-title>
<source>J Biol Chem</source>
<year>2013</year>
<volume>288</volume>
<fpage>17812</fpage>
<lpage>17822</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M113.468975</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>[25]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNees</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>White</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Zanwar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vilchez</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Butel</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR</article-title>
<source>J Clin Virol</source>
<year>2005</year>
<volume>34</volume>
<fpage>52</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcv.2004.12.018</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>[26]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imamichi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Adelsberger</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Baseler</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>HC</given-names>
</name>
</person-group>
<article-title>Actinomycin D induces high-level resistance to thymidine analogs in replication of human immunodeficiency virus type 1 by interfering with host cell thymidine kinase expression</article-title>
<source>J Virol</source>
<year>2003</year>
<volume>77</volume>
<fpage>1011</fpage>
<lpage>1020</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>[27]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oguariri</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Brann</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Imamichi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors</article-title>
<source>J Biol Chem</source>
<year>2007</year>
<volume>282</volume>
<fpage>3594</fpage>
<lpage>3604</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M608150200</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Evaluation of anti-HIV effect of S100A8/A9, S100A8 and S100A9 in primary cells.</title>
<p>(a-b) T-cells (a) and MDMs (b) were infected with HIV-1 and then cultured in the presence of different concentrations of S100A8/A9 combination. As a positive control of TLR4 stimulation, 10 ng/ml of LPS (Sigma Aldrich) was used. Each assay was performed in quadruplicate and half of the culture supernatants were changed in all experiments on every 3<sup>rd</sup> or 4<sup>th</sup> day with the fresh media containing the same concentration of the recombinant proteins. HIV-1 replication was monitored HIV p24 antigen in the culture supernatant by a p24 antigen capture assay. Data show means + SD and are representatives of three independent experiments. (c and d) HIV-infected T cells (c) and MDMs (d) were cultured in the presence of different concentrations of S100A8 or S100A9. Each assay was performed in quadruplicate. HIV-1 replication was monitored HIV p24 antigen in the culture supernatant by a p24 antigen capture assay. Data show means + SD. and are representatives of three independent experiments. (e) MDMs were pulse-treated with S100A8 or S100A9 for 24 hr, and then the treated cells were infected with HIV. The infected MDMs were culture for 14 days in the absence of S100 proteins with changing fresh medium on every 3<sup>rd</sup> or 4<sup>th</sup> day. HIV-1 replication was monitored HIV p24 antigen in the culture supernatant by a p24 antigen capture assay. Data show means + SE (n=3). (f and g) CD4 (f) and CCR5 (g) expression on the treated cells were compared to that on untreated cells. Back shows isotype control, gray, red and blue histogram indicate untreated cells, S100A8 and S100A9-treated cells, respectively. Data shows a representative of three independent experiments. (h) The binding assay was performed using the pretreated MDMs. The cells were incubated with HIV on ice for two hr to allow virus binding. Virus RNA on cell surface was determined by qRT-PCR. The data show the means ± SE of three independent experiments. (i) MDM cells were pretreated with S100A8 and S100A9 for 24 h at 37°C. Cells were washed and infected with HIV for 2 h. The cells were washed and then cultured for an additional 24 h in the absence of recombinant proteins. The genomic DNA was isolated and used in qPCR for quantification of proviral DNA copy numbers. A standard curve was generated using serial dilutions of plasmids encoding HIVgag or RNaseP gene to obtain absolute proviral DNA copy numbers as previously described[<xref ref-type="bibr" rid="R23">23</xref>]. The results represent DNA copy numbers per 1 × 10<sup>6</sup> cells. The data show the means ± SE from three independent experiments. (j and k) Expression levels of SPTBN1 in MDMs in whole-cell lysates from two independent donors’ cells were compared by Western blotting using an anti-SPTBN1 antibody (Abcam)[<xref ref-type="bibr" rid="R23">23</xref>]. As an internal control, anti-b-actin (Sigma Aldrich) was used. The intensity of Western blot bands was analyzed using the ImageJ (NIH). Statistical analysis was done using Prism (GraphPad). Statistical significance was determined by the Student’s t test. A p value&lt;0.05 was considered a significant difference. * p&lt;0.05, **p&lt;0.01.</p>
<p>Short version</p>
</caption>
<graphic xlink:href="EMS137319-f001"/>
</fig>
</floats-group>
</article>
